当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析

立方制药

(003020)

  

流通市值:24.31亿  总市值:33.97亿
流通股本:1.14亿   总股本:1.60亿

立方制药(003020)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.73亿元,每股收益1.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益175084.88万元,未分配利润87085.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产221715.08万元,负债46630.20万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,524,501,6531,267,790,879.76811,816,8182,579,340,227.28
营业总成本1,357,619,917.081,134,992,117.8730,374,001.922,376,803,278.74
营业利润191,331,372.5147,020,188.9577,924,247.11240,054,921.89
利润总额190,907,405.04146,649,264.2878,034,457.25239,823,316.33
净利润172,830,684.68131,129,250.166,141,680.02209,607,566.84
其他综合收益----
综合收益总额172,830,684.68131,129,250.166,141,680.02209,607,566.84
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,073,366,087.71,072,710,205.41,557,043,251.171,452,547,083.2
非流动资产合计1,143,784,696.63886,638,709.15748,982,013.65669,208,802.47
资产总计2,217,150,784.331,959,348,914.552,306,025,264.822,121,755,885.67
流动负债合计436,859,817.98375,541,360.23736,124,446.1622,628,241.28
非流动负债合计29,442,184.5521,920,539.3817,109,261.4818,906,582.98
负债合计466,302,002.53397,461,899.61753,233,707.58641,534,824.26
归属于母公司股东权益合计1,604,748,382.261,561,887,014.941,552,791,557.241,480,221,061.41
股东权益合计1,750,848,781.81,561,887,014.941,552,791,557.241,480,221,061.41
负债和股东权益合计2,217,150,784.331,959,348,914.552,306,025,264.822,121,755,885.67
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,486,252,577.831,041,560,315.06634,636,626.422,547,895,004.12
经营活动现金流出小计1,424,269,350.47981,905,940.47613,035,717.092,347,256,879.46
经营活动产生的现金流量净额61,983,227.3659,654,374.5921,600,909.33200,638,124.66
投资活动现金流入小计453,137,668.12100,054,862.13-1,358.92984,641,657.3
投资活动现金流出小计934,233,455.38543,180,341.3401,060,831.391,186,446,495.18
投资活动产生的现金流量净额-481,095,787.26-443,125,479.17-401,062,190.31-201,804,837.88
筹资活动现金流入小计115,544,527.74110,855,827.7442,452,002.4427,813,826.3
筹资活动现金流出小计70,997,467.7468,120,100.193,175,866.5575,762,616.95
筹资活动产生的现金流量净额44,547,06042,735,727.5539,276,135.89-47,948,790.65
汇率变动对现金及现金等价物的影响45,288.2845,917.01-3,938.58403,046.56
现金及现金等价物净增加额-374,520,211.62-340,689,460.02-340,189,083.67-48,712,457.31
期末现金及现金等价物余额202,708,102.33236,538,853.93237,039,230.28577,228,313.95
TOP↑